市场调查报告书
商品编码
1410744
经导管二尖瓣移植术(TMVI)的全球市场 - 市场规模(各市场区隔),占有率,法规,偿付,治疗,预测(~2033年)Transcatheter Mitral Valve Implantation (TMVI) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
本报告提供全球经导管二尖瓣移植术(TMVI)市场相关调查分析,提供各市场区隔的市场规模,市场趋势,竞争情形,COVID-19影响等资讯。
市场模式的主要内容如下列。
已上市的经导管二尖瓣移植术(TMVI)与不断变化的竞争格局
世界,地区,国家层级的市场固有考察
透过掌握包含医疗制度概要的真实整体状况来促进对市场的认识。此外在打入市场部门更提供关于给付原则及法规情势之资讯,使您能够更深入地研究市场动态。
对象企业
Transcatheter Mitral Valve Implantation (TMVI) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Transcatheter Mitral Valve Implantation (TMVI) market for the year 2020 and beyond. Transcatheter Mitral Valve Implantation (TMVI) are used to treat aortic aneurysms and dissections. Aortic aneurysms can occur in both the thoracic aorta (Thoracic Aortic Aneurysms - TAA) and abdominal aorta (Abdominal Aortic Aneurysms - AAA). Aortic aneurysms occur when the walls of the aorta weaken, resulting in a large swelling and weakening of the aortic wall.
Abdominal Transcatheter Mitral Valve Implantation (TMVI) are used to treat abdominal aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. Thoracic Transcatheter Mitral Valve Implantation (TMVI) are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. Leg extensions are additional extensions which are used in conjunction with the stent graft to extend the length of the stent graft.
Each of the covered 27 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Transcatheter Mitral Valve Implantation (TMVI) market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable